Congress does need to review and better understand drug pricing to ensure that we are incentivizing research and innovation and development of new drug treatments and cures without creating loopholes that can be taken advantage of.
Eshoo calls for Congressional review of drug pricing to promote innovation without exploitation.
Share
More from Anna Eshoo
I thank the ranking member for yielding time to me, and I thank him for support of my bill, the Securing Semiconductor Supply Chains Act of 2023. My congressional district was named for the materials that semiconductors are made…
Today, the House will vote on my legislation, H.R. 3433, the Give Kids a Chance Act. My thanks to Reps. Michael McCaul (R-TX) and Gus Bilirakis (R-FL), the chairwoman of the Energy and Commerce Committee Cathy McMorris Rodgers (R-WA) and…
universal high-speed internet is necessary for our country's competitiveness in the 21st century.
Other voices in this conversation
